Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @avillach
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @avillach
-
Paul Avillach proslijedio/la je Tweet
Al Gore may not have invented the internet, but David Clark did. Come and hear an inventor of TCP/IP at the
@bos_chip Landmark Ideas Series. February 13th at 4pm. http://www.childrenshospital.org/research/departments-divisions-programs/programs/chip/landmark-ideas …pic.twitter.com/MgOC1K0oUu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Congratulation to
@HarvardDBMI now engaged in a waste reduction chalenge with http://www.spare-it.com#Sustainability#people-empowerment#DataDrivenpic.twitter.com/91hetKd7vz
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Data driven *Waste reduction pilot* starting today
@HarvardDBMI @harvardmed with the help of @Spareit1pic.twitter.com/lRmjpNWPpoOvo je potencijalno osjetljiv multimedijski sadržaj. Saznajte više
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Our
#FAIRshake https://fairshake.cloud/ ms is out@CellSystemsCP https://www.cell.com/cels/newarticles … This is a product of@nih_dcppc with contributions from@MaayanLab@SusannaASansone@ctitusbrown@micheldumontier@JasonWilliamsNY@juergen_a_klenk@procrastinomics@NIH_CommonFund & otherspic.twitter.com/hATbTLFvA7
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Congratulations to
@KharchenkoLab and collaborators at@institut_curie,@karolinskainst, and Medical U of Vienna on their European Research Council Synergy Grant, for research to make potential cancer cells pause and either reverse course or self-destruct. https://hms.harvard.edu/news/major-grant-study-cell-fate-cancer …https://twitter.com/EU_Commission/status/1182602877631680513 …
0:37Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Paul Avillach proslijedio/la je Tweet
It’s friday my friends! Le meilleur gars au monde! Bon week-end à tous.pic.twitter.com/QgO0BzHczE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
I recently had the honor of being named the Nature Research Award winner for 2019. I just wanted to provide here a full transcript of my award acceptance speech as I had intended to deliver it: https://jean.fan/2019/10/16/nature-research-award.html …
#AcademicTwitter#phdchat#WomenInSTEM#WomenWhoCodehttps://twitter.com/Magda_Skipper/status/1184223085274292225 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
1/3 Wonderful to finally be able to share our paper on the development and deployment of milasen, now online at https://www.nejm.org/doi/full/10.1056/NEJMoa1813279 …. It’s accompanied by thoughtful commentary from Janet Woodcock and Peter Marks of the FDA (https://www.nejm.org/doi/full/10.1056/NEJMe1911295 …).
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Authors describe how molecular diagnosis of a rare, fatal neurodegenerative condition led to the rational design, testing, and manufacture of milasen, a splice-modulating antisense oligonucleotide drug tailored to a particular patient. https://nej.md/30YbI1M
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Spectacular work on making science leap to effective treatment
@ParkLabGenomics@HarvardDBMI w visionary leadership by@Timur@BostonChildrens nice@NEJM summaryhttps://twitter.com/ParkLabGenomics/status/1182051435413815297 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
I don't remember who posted this on Twitter a few years ago, but whoever you are: you have improved every night I've spent in a hotel since.pic.twitter.com/NpuuumqHV8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Excited to be back at Boston Children’s, moderating a panel on the future of drug development at the 25th Anniversary of the Children’s Hospital Informatics Program (
#CHIP25), with old friends Ken Mandl@mandl Zak Kohane@zakkohane, COO Kevin Churchwell and the inimitable DGN.pic.twitter.com/xVbSH8MrII
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
#CHIP25 getting a glimpse of the 1994 mind of@zakkohane — surviving the AI winter by building up the electronic platforms for health data; hanging on to mentors —Pete Szolovits, Joe Majzoub; remember the important of simplicity and heuristics, & clinically-inspired informaticsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Joe Majzoub’s notes about the founding of CHIP—among other things, they asked for no resources
#CHIP25@Bos_CHIPpic.twitter.com/OmSSmSK7AI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Of the 151 US med schools in the United States, how many (1) have all their students sequence their genome (or another person)? Zero (2) have a formal
#AI curriculum#AI? Zero (3) give a smartphone ultrasound probe to all their students? 1 (@UCIrvineSOM) https://jamanetwork.com/journals/jama/fullarticle/2749577 …pic.twitter.com/c2jlcCgOT8
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Sharing multimodal patient data across hospitals or study cohorts to advance precision medicine
@avillach@HarvardDBMI w API access for authorized investigators.pic.twitter.com/H8BSA6N0fg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Beyond the VUS (variant of unknown significance): A scalable, federated reference population for genomic insights across three leading children’s hospitals. https://www.nature.com/articles/s41436-019-0646-3 …
@BostonChildrens@ChildrensPhila@CincyChildrensHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Beware causal inference with machine learning because the answer isn’t in the training data, and the algorithm can only learn what it sees.
#causalinference#ML#AIpic.twitter.com/RruvFGTdHWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Avillach proslijedio/la je Tweet
Technology will not always be used in the way intended by the designers. People in Japan are renting cars but not driving them. But they are using the vehicles to charge phones, store luggage, and take a nap.https://www.theverge.com/2019/7/5/20683406/japan-car-sharing-renting-not-driving-private-space-orix-times24?utm_campaign=theverge&utm_content=entry&utm_medium=social&utm_source=twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
We're pleased to announce €363 million in grants for 37 research groups that won this year’s European Research Council Synergy Grants, aimed at tackling some of the most complex global challenges.
Learn more →